Video : DAPT meets its MASTER webinar

It looks like you're using an obsolete version of internet explorer. Internet explorer is no longer supported by Microsoft since the end of 2015. We invite you to use a newer browser such as Firefox, Google Chrome or Microsoft Edge.

Wednesday, March 30^th 2022 - 06pm to 07pm (GMT+2)

Cardiology / Coronary / Pci / Webinar

My Player placeholder

Become an Incathlab member and receive full access to its content!

You must be an Incathlab member to access videos without any restrictions. Register for free in one minute and access all services provided by Incathlab.You will also be able to log into Incathlab from your Facebook or twitter account by clicking on login on the top-right corner of Incathlab website.

Registration Login

Worldwide schedules comment Share

DESCRIPTION

This program has been built in 2 episodes:

Part 1: The unknown HBR patient
Part 2: When DAPT meets OAC - what to do?

Agenda:

	Introduction
	Expert discussion on treatment option of HBR patients with an OAC indication
	Different Clinical scenarios
	Conclusion & take home message

Objectives:

Extending the MASTER DAPT* discussion to OAC patients:

Understand pre & peri-procedural considerations for an OAC patient attending the cathlab
Discuss optimal dosing & duration of triple therapy
Consider long term role of antiplatelet therapy in OAC patient post-PCI

* MASTER DAPT included patients at high bleeding risk who had undergoneimplantation of Ultimaster™ family stent; results may not extend to patients who arenot at high bleeding risk or who receive other stent types. MASTER DAPT study issponsored by the European Cardiovascular Research Institute (ECRI, Rotterdam, TheNetherlands) and supported with a restricted research grant by Terumo Europe.Ultimaster™ Tansei™ and Ultimaster™ DES are not available for sales in all countries.Please contact your Terumo local sales representatives for more information.

Shooting date : 2022-03-30
Last update : 2022-04-11